Impact of Metabolic Syndrome on Development of Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention Among Nondiabetic Patients

Ozcan, Ozgur; Er, Hacer; GÜLEÇ, HASAN; Ustun, Elif; GEREDE ULUDAĞ, DEMET; Goksuluk, Huseyin; TULUNAY KAYA, CANSIN; EROL, ÇETİN

doi:10.1002/clc.22364

Impact of Metabolic Syndrome on Development of Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention Among Nondiabetic Patients

Ozcan O. U., Er H. A., GÜLEÇ H. S., Ustun E. E., GEREDE ULUDAĞ D. M., Goksuluk H., ...Daha Fazla

CLINICAL CARDIOLOGY, cilt.38, sa.3, ss.150-156, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 38 Sayı: 3
Basım Tarihi: 2015
Doi Numarası: 10.1002/clc.22364
Dergi Adı: CLINICAL CARDIOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.150-156
Ankara Üniversitesi Adresli: Evet

Özet

BackgroundIdentifying patients who are vulnerable to development of contrast-induced nephropathy (CIN) is essential because of its association with prolonged hospitalization, increased cost, and increased in-hospital and long-term mortality rates.